LTBR and autoimmune disease: LTβR-Ig has been shown to alleviate various autoimmune diseases in mouse models of rheumatoid arthritis, colitis, experimental autoimmune encephalomyelitis (EAE), and late stage of type 1 diabetes [82,83,84,85].